Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRCPP1, or prolylcarboxypeptidase pseudogene 1, is a pseudogene related to the functional PRCP gene. The true PRCP gene encodes a lysosomal serine protease that regulates peptides involved in blood pressure and inflammation and is a potential drug target[1][3][4]. However, PRCPP1 itself does not produce a functional protein and is not known to be involved in biological processes, disease, or therapy. A pseudogene is a DNA sequence similar to a known gene but generally nonfunctional due to mutations, truncations, or lack of regulatory elements. Several genomic resources identify PRCPP1 only as a non-coding sequence located on chromosome 2, distinguished from the functional PRCP gene which has clinical and pharmacological relevance[1][3]. PRCPP1 is not cited in databases as a therapeutic target, biomarker, or drug interaction partner. Key clarification: - PRCPP1 is frequently confused with the functional prolylcarboxypeptidase (PRCP), which is an enzyme with biological and therapeutic significance. The search results confirm PRCPP1 is a pseudogene corresponding to PRCP and does not have direct biological functions or therapeutic relevance[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prolylcarboxypeptidase pseudogene 1 (PRCPP1).